GLENMEDE TRUST CO NA - NEOGENOMICS INC ownership

NEOGENOMICS INC's ticker is NEO and the CUSIP is 64049M209. A total of 279 filers reported holding NEOGENOMICS INC in Q3 2023. The put-call ratio across all filers is 0.32 and the average weighting 0.1%.

Quarter-by-quarter ownership
GLENMEDE TRUST CO NA ownership history of NEOGENOMICS INC
ValueSharesWeighting
Q3 2023$13,707,009
-29.8%
1,114,391
-1.1%
0.08%
-29.7%
Q2 2023$19,528,321
-0.3%
1,126,881
+0.2%
0.11%0.0%
Q1 2023$19,579,477
+91.0%
1,124,611
+1.4%
0.11%
+85.0%
Q4 2022$10,250,356
-5.3%
1,109,346
-11.8%
0.06%
-11.8%
Q3 2022$10,824,000
+12.1%
1,257,286
+6.1%
0.07%
+19.3%
Q2 2022$9,653,000
+16.0%
1,184,671
+73.0%
0.06%
+39.0%
Q1 2022$8,321,000
-48.9%
684,883
+43.4%
0.04%
-46.8%
Q4 2021$16,292,000
+0.1%
477,513
+41.5%
0.08%
-8.3%
Q3 2021$16,275,000
+4.4%
337,389
-2.2%
0.08%
+3.7%
Q2 2021$15,584,000
-6.8%
345,024
-0.5%
0.08%
-10.0%
Q1 2021$16,717,000
-28.2%
346,641
-19.9%
0.09%
-29.7%
Q4 2020$23,296,000
-1.6%
432,718
-32.6%
0.13%
-9.9%
Q3 2020$23,667,000
+4.8%
641,586
-12.0%
0.14%
+2.9%
Q2 2020$22,593,000
-27.3%
729,296
-31.3%
0.14%
-2.8%
Q1 2020$31,071,0000.0%1,062,2660.0%0.14%0.0%
Q4 2019$31,071,000
+35.0%
1,062,266
-11.8%
0.14%
+35.2%
Q3 2019$23,022,000
-19.4%
1,204,147
-7.5%
0.10%
-16.0%
Q2 2019$28,565,000
+612.3%
1,302,016
+564.1%
0.12%
+594.4%
Q1 2019$4,010,000
+36354.5%
196,046
+22052.1%
0.02%
Q4 2018$11,000
-90.4%
885
-88.2%
0.00%
Q3 2018$114,0007,5250.00%
Other shareholders
NEOGENOMICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
KOPP INVESTMENT ADVISORS LLC 396,327$8,109,0006.56%
Cowen Prime Services LLC 584,766$11,964,0006.20%
1492 Capital Management LLC 269,488$5,514,0004.67%
First Light Asset Management, LLC 1,604,611$32,830,0004.27%
PERKINS CAPITAL MANAGEMENT INC 264,650$5,415,0003.56%
FALCON POINT CAPITAL, LLC 219,992$4,501,0002.45%
Granite Investment Partners, LLC 1,764,090$36,093,0002.05%
Ranger Investment Management 1,209,535$24,747,0001.79%
EMERALD ADVISERS, LLC 1,878,901$38,442,0001.56%
EMERALD MUTUAL FUND ADVISERS TRUST 1,875,759$38,378,0001.54%
View complete list of NEOGENOMICS INC shareholders